ORCA
Online Research @ CardiffÂ
Browse by All Cardiff Authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 3.
Harding, Katharine, Williams, Owain, Willis, Mark  ORCID: https://orcid.org/0000-0003-3024-6063, Hrastelj, James ORCID: https://orcid.org/0000-0002-7991-5259, Rimmer, Anthony, Joseph, Fady, Tomassini, Valentina ORCID: https://orcid.org/0000-0002-7368-6280, Wardle, Mark, Pickersgill, Trevor, Robertson, Neil ORCID: https://orcid.org/0000-0002-5409-4909 and Tallantyre, Emma ORCID: https://orcid.org/0000-0002-3760-6634
2019.
Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis.
JAMA Neurology
76
(5)
, pp. 536-541.
10.1001/jamaneurol.2018.4905
|
|
| Carne, Emily, Ponsford, Mark, El-Shanawany, Tariq, Williams, Paul, Pickersgill, Trevor and Jolles, Stephen 2015. Five years of self-administered hyaluronidase facilitated subcutaneous immunoglobulin (fSCIg) home therapy in a patient with primary immunodeficiency. Journal of Clinical Pathology 69 (1) , pp. 87-88. 10.1136/jclinpath-2015-202901 |
|
|
|
Cossburn, Mark D., Harding, Katharine, Ingram, Gillian, El-Shanawany, Tariq, Heaps, Adrian, Pickersgill, Trevor Paul, Jolles, Stephen and Robertson, Neil ORCID: https://orcid.org/0000-0002-5409-4909
2013.
Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis.
Neurology
80
(1)
, pp. 55-61.
10.1212/WNL.0b013e31827b5927
|
|
|